Blood Urea Nitrogen

Blood Urea Nitrogen, or BUN, is a kidney biomarker. It is a reported measurement that helps describe where this marker fits among other kidney biomarkers and how its result should be read in context.

Blood Urea Nitrogen is measured from a serum sample, meaning the test uses the liquid portion of blood. Fasting is not required for this measurement, so an overnight fast is not part of the stated collection requirement.

The result is interpreted against a reference range, with a separate optimal range indicating the interval associated with the preferred result category. Sex-specific reference ranges are also shown, so the appropriate comparison depends on the reference category used for the individual. Blood Urea Nitrogen may be considered alongside Creatinine and Egfr when reviewing kidney-related results. A clinician can explain how these markers and the applicable reference range should be interpreted together.

Blood Urea Nitrogen is reported from a serum sample in mg/dL. Read the result against the reference range printed on the same report, including the applicable sex-specific range when one is provided. Laboratories may use different ranges or units, so a number should not be interpreted by comparing it with an interval from another report or source.

The reference range is the broader interval used for comparison, while the optimal range is narrower and sits within it. A result can therefore fall inside the reference range without being inside the tighter optimal range; these categories should not be treated as interchangeable.

Fasting is not required for this measurement. A single value is not a diagnosis and should be considered alongside the clinical context. Results outside the report’s reference range belong with a clinician, who can determine what follow-up, if any, is appropriate.

Blood Urea Nitrogen is considered optimal within a range, so a lower value is not automatically better than a value within that range. Directly measured trials reported decreases with several interventions, including Resveratrol, Astragalus, Berberine, Ginkgo Biloba, Saffron Extract, Quercetin, Cordyceps, Dietary Fiber (Prebiotics), Melatonin, Lycopene, and Tribulus Terrestris. The reported decrease pattern therefore spans multiple types of interventions, but it should not be interpreted as a universal or treatment-like effect.

Other directly measured interventions were unchanged: Curcumin, Vitamin E, Milk Thistle (Silymarin), and Garlic. These findings illustrate why the marker should be interpreted by direction and context rather than by assuming that any supplement associated with a change is beneficial. Some reported decreases were not consistent across every study, and the meaning of a change depends on whether the result remains within the desired range.

The typical time to recheck varied substantially, from 1.0 to 32.0 weeks. Results may therefore reflect different intervention periods and study contexts rather than a single expected timeline. For a medical condition, changes in Blood Urea Nitrogen are best interpreted with a clinician alongside the broader clinical picture.